1-2 of 2
Elaine Barrie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202

Florence I. Raynaud, Steven R. Whittaker, Peter M. Fischer, Steven McClue, Michael I. Walton, S. Elaine Barrie, Michelle D. Garrett, Paul Rogers, Simon J. Clarke, Lloyd R. Kelland, Melanie Valenti, Lisa Brunton, Suzanne Eccles, David P. Lane, Paul Workman
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4875–4887.
https://doi.org/10.1158/1078-0432.CCR-04-2264
Published: 01 July 2005
View article titled, <em>In vitro</em> and <em>In vivo</em> Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202
Open the PDF for <em>In vitro</em> and <em>In vivo</em> Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202 in another window
Journal Articles

Establishment and Characterization of Acquired Resistance to the Farnesyl Protein Transferase Inhibitor R115777 in a Human Colon Cancer Cell Line

Victoria Smith, Martin G. Rowlands, Elaine Barrie, Paul Workman, Lloyd R. Kelland
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 2002–2009.
Published: 01 June 2002
View article titled, Establishment and Characterization of Acquired Resistance to the Farnesyl Protein Transferase Inhibitor R115777 in a Human Colon Cancer Cell Line
Open the PDF for Establishment and Characterization of Acquired Resistance to the Farnesyl Protein Transferase Inhibitor R115777 in a Human Colon Cancer Cell Line in another window